HLA-A*0201 & B2M & Glycipan 3

HLA-A*0201 & B2M & Glycipan 3

Demande de produit

Asset Licensing Opportunity
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
IMGS-001IMGS-001Phase 1 ClinicalThe University Of Texas MD Anderson Cancer Center
Solid tumours; Neoplasms; Triple Negative Breast Neoplasms; Prostatic Neoplasms; Colorectal Neoplasms
Details
Customer Reviews